Communication about the risks and benefits of phase I pediatric oncology trials.
Hazen RA, Zyzanski S, Baker JN, Drotar D, Kodish E. Communication about the risks and benefits of phase I pediatric oncology trials. Contemp Clin Trials. 2015 Mar; 41:139-45.